Financial Summary -
Raguse Medizinische Produkte România Srl
Unique identification code:9521827
Registration number:J1997000265328
Nace:2660
Sales - Ron
3.722.070
Net Profit - Ron
99.191
Employees
194
Open Account
Company Raguse Medizinische Produkte România Srl with Fiscal Code 9521827
recorded a turnover of 2024 of
3.722.070,
with a net profit of
99.191
and having an average number of employees of
194.
The company operates in the field of Fabricarea de echipamente pentru radiologie, electrodiagnostic şi electroterapie having the NACE code 2660.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Raguse Medizinische Produkte România Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
2.646.178
2.314.494
2.357.742
3.314.547
3.184.430
2.933.309
3.191.653
2.999.784
3.373.629
3.722.070
Total Income - EUR
2.709.086
2.406.217
2.438.522
3.375.540
3.241.204
2.981.527
3.275.237
3.044.702
3.412.842
3.743.976
Total Expenses - EUR
2.464.688
2.399.399
2.509.658
3.112.160
3.253.064
3.071.471
3.225.200
3.049.522
3.290.771
3.625.786
Gross Profit/Loss - EUR
244.398
6.818
-71.136
263.380
-11.860
-89.943
50.037
-4.820
122.071
118.190
Net Profit/Loss - EUR
207.918
893
-112.180
242.490
-11.860
-89.943
50.037
-4.820
105.211
99.191
Employees
252
228
238
280
310
264
265
204
218
194
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 10.9%, from 3.373.629 euro in the year 2023, to 3.722.070 euro in 2024.
The Net Profit decreased by -5.432 euro, from 105.211 euro in 2023, to 99.191 in the last year.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Raguse Medizinische Produkte România Srl - CUI 9521827
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
1.841.487
2.500.700
2.321.789
2.306.400
2.203.134
2.080.954
1.974.689
1.809.642
2.201.055
2.587.006
Current Assets
51.876
145.398
126.302
100.089
86.191
74.255
65.394
40.362
104.069
113.349
Inventories
11.865
16.083
25.249
23.593
13.152
14.939
13.744
5.914
1.754
1.559
Receivables
30.551
39.075
38.889
59.513
41.812
57.604
45.256
28.673
73.031
79.263
Cash
9.460
90.240
62.164
16.983
31.228
1.712
6.395
5.776
29.283
32.527
Shareholders Funds
1.022.467
1.012.933
883.612
1.138.206
1.104.304
993.426
1.021.432
1.019.781
1.121.900
1.419.934
Social Capital
452.643
448.027
440.446
432.363
423.990
415.952
406.728
407.989
406.752
404.479
Debts
866.390
1.611.958
1.538.008
1.234.748
1.167.259
1.162.676
1.014.670
822.093
1.162.022
1.268.907
Income in Advance
0
0
0
0
0
0
0
0
580
664
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"2660 - 2660"
CAEN Financial Year
2660
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
113.349 euro in 2024 which includes Inventories of
1.559 euro, Receivables of
79.263 euro and cash availability of
32.527 euro.
The company's Equity was valued at
1.419.934 euro, while total Liabilities amounted to
1.268.907 euro.
Equity increased by 304.304 euro, from 1.121.900 euro in 2023, to 1.419.934 in 2024.
The Debt Ratio was 47.2% in the year 2024.
Reviews - Raguse Medizinische Produkte România Srl
Comments - Raguse Medizinische Produkte România Srl
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Raguse Medizinische Produkte România Srl